Terms: = Bone cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Clinical Outcome
33 results:
1. Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
Sauta E; Robin M; Bersanelli M; Travaglino E; Meggendorfer M; Zhao LP; Caballero Berrocal JC; Sala C; Maggioni G; Bernardi M; Di Grazia C; Vago L; Rivoli G; Borin L; D'Amico S; Tentori CA; Ubezio M; Campagna A; Russo A; Mannina D; Lanino L; Chiusolo P; Giaccone L; Voso MT; Riva M; Oliva EN; Zampini M; Riva E; Nibourel O; Bicchieri M; Bolli N; Rambaldi A; Passamonti F; Savevski V; Santoro A; Germing U; Kordasti S; Santini V; Diez-Campelo M; Sanz G; Sole F; Kern W; Platzbecker U; Ades L; Fenaux P; Haferlach T; Castellani G; Della Porta MG
J Clin Oncol; 2023 May; 41(15):2827-2842. PubMed ID: 36930857
[TBL] [Abstract] [Full Text] [Related]
2. clinical outcomes of Scanning Carbon-ion Radiotherapy for Soft Tissue Sarcoma of the Extremities.
Takakusagi Y; Serizawa I; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Katoh H; Hiruma T; Kamada T
Anticancer Res; 2022 Jul; 42(7):3701-3706. PubMed ID: 35790269
[TBL] [Abstract] [Full Text] [Related]
3. Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients.
Trentini F; Mazzaschi G; Milanese G; Pavone C; Madeddu D; Gnetti L; Frati C; Lorusso B; Lagrasta CAM; Minari R; Ampollini L; Ledda RE; Silva M; Sverzellati N; Quaini F; Roti G; Tiseo M
Tumori; 2022 Feb; 108(1):86-92. PubMed ID: 33730957
[TBL] [Abstract] [Full Text] [Related]
4. Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma.
Chen Y; Zhao B; Wang X
BMC Cancer; 2020 Oct; 20(1):1022. PubMed ID: 33087099
[TBL] [Abstract] [Full Text] [Related]
5. [New system combining Hyams grading system and modified Kadish stage to evaluate the progress of esthesioneuroblastoma].
Lai YY; Lin TJ; Jiang LJ; Deng J; Zuo KJ; Zhang Y; Shi JB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):599-602. PubMed ID: 31327194
[No Abstract] [Full Text] [Related]
6. CD97 expression is associated with poor overall survival in acute myeloid leukemia.
Vaikari VP; Yang J; Wu S; Alachkar H
Exp Hematol; 2019 Jul; 75():64-73.e4. PubMed ID: 31260716
[TBL] [Abstract] [Full Text] [Related]
7. Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor.
Thysell E; Vidman L; Ylitalo EB; Jernberg E; Crnalic S; Iglesias-Gato D; Flores-Morales A; Stattin P; Egevad L; Widmark A; Rydén P; Bergh A; Wikström P
Mol Oncol; 2019 Aug; 13(8):1763-1777. PubMed ID: 31162796
[TBL] [Abstract] [Full Text] [Related]
8. Diagnosis and treatment of hindfoot osteoid osteoma: A therapeutic method for each case.
Mellado-Romero MA; Vilá-Rico J; Gallego-Herrero C; Sánchez-Herraéz S; Casas-Ramos P; Santos-Sánchez JA; Ramos-Pascua LR
Rev Esp Cir Ortop Traumatol (Engl Ed); 2019; 63(3):165-172. PubMed ID: 30922598
[TBL] [Abstract] [Full Text] [Related]
9. A comparison of treatment outcome between fiducial-based and bone-based image guided radiotherapy in prostate cancer patients.
Napieralska A; Majewski W; Kulik R; Głowacki G; Miszczyk L
Radiat Oncol; 2018 Nov; 13(1):235. PubMed ID: 30482212
[TBL] [Abstract] [Full Text] [Related]
10. The Terry Fox Research Institute Canadian Prostate cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation.
Ouellet V; Aprikian A; Bergeron A; Brimo F; Bristow RG; Chevalier S; Drachenberg D; Fazli L; Fleshner NE; Gleave M; Karakiewicz P; Klotz L; Lacombe L; Lattouf JB; van der Kwast T; Squire JA; Latour M; Trudel D; Mes-Masson AM; Saad F
BMC Urol; 2018 Sep; 18(1):78. PubMed ID: 30200929
[TBL] [Abstract] [Full Text] [Related]
11. Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma.
Smida J; Xu H; Zhang Y; Baumhoer D; Ribi S; Kovac M; von Luettichau I; Bielack S; O'Leary VB; Leib-Mösch C; Frishman D; Nathrath M
Int J Cancer; 2017 Aug; 141(4):816-828. PubMed ID: 28494505
[TBL] [Abstract] [Full Text] [Related]
12. Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Todisco E; Ciceri F; Boschini C; Giglio F; Bacigalupo A; Patriarca F; Donnini I; Alessandrino EP; Arcese W; Iori AP; Marenco P; Cavattoni I; Chiusolo P; Terruzzi E; Castagna L; Santoro A; Bosi A; Oldani E; Bruno B; Bonifazi F; Rambaldi A
Bone Marrow Transplant; 2017 Jul; 52(7):955-961. PubMed ID: 28067875
[TBL] [Abstract] [Full Text] [Related]
13. Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib.
Lu X; Gu W; Zhang H; Zhu Y; Shi G; Ye D
Oncotarget; 2016 May; 7(18):26879-87. PubMed ID: 27058898
[TBL] [Abstract] [Full Text] [Related]
14. Significance of KIT exon 17 mutation depends on mutant level rather than positivity in core-binding factor acute myeloid leukemia.
Jang W; Yoon JH; Park J; Lee GD; Kim J; Kwon A; Choi H; Han K; Nahm CH; Kim HJ; Min WS; Kim M; Kim Y
Blood Cancer J; 2016 Jan; 6(1):e387. PubMed ID: 26771813
[TBL] [Abstract] [Full Text] [Related]
15. A gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer.
Luis-Ravelo D; Antón I; Zandueta C; Valencia K; Ormazábal C; Martínez-Canarias S; Guruceaga E; Perurena N; Vicent S; De Las Rivas J; Lecanda F
Oncogene; 2014 Oct; 33(43):5090-9. PubMed ID: 24166494
[TBL] [Abstract] [Full Text] [Related]
16. Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery.
Posthumadeboer J; Piersma SR; Pham TV; van Egmond PW; Knol JC; Cleton-Jansen AM; van Geer MA; van Beusechem VW; Kaspers GJ; van Royen BJ; Jiménez CR; Helder MN
Br J Cancer; 2013 Oct; 109(8):2142-54. PubMed ID: 24064975
[TBL] [Abstract] [Full Text] [Related]
17. Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
Pellagatti A; Benner A; Mills KI; Cazzola M; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Verma A; McDonald EJ; Killick S; Hellström-Lindberg E; Bullinger L; Wainscoat JS; Boultwood J
J Clin Oncol; 2013 Oct; 31(28):3557-64. PubMed ID: 24002510
[TBL] [Abstract] [Full Text] [Related]
18. A 36-gene signature predicts clinical progression in a subgroup of ERG-positive prostate cancers.
Gasi Tandefelt D; Boormans JL; van der Korput HA; Jenster GW; Trapman J
Eur Urol; 2013 Dec; 64(6):941-50. PubMed ID: 23490727
[TBL] [Abstract] [Full Text] [Related]
19. RchyOptimyx: cellular hierarchy optimization for flow cytometry.
Aghaeepour N; Jalali A; O'Neill K; Chattopadhyay PK; Roederer M; Hoos HH; Brinkman RR
Cytometry A; 2012 Dec; 81(12):1022-30. PubMed ID: 23044634
[TBL] [Abstract] [Full Text] [Related]
20. Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.
Capulli M; Angelucci A; Driouch K; Garcia T; Clement-Lacroix P; Martella F; Ventura L; Bologna M; Flamini S; Moreschini O; Lidereau R; Ricevuto E; Muraca M; Teti A; Rucci N
J Bone Miner Res; 2012 Nov; 27(11):2387-98. PubMed ID: 22714395
[TBL] [Abstract] [Full Text] [Related]
[Next]
